Dren Bio has closed an oversubscribed $350 million private financing round to advance its lead antibody candidate toward ...

Flagship has merged 3 of its own portfolio companies into a single powerhouse aimed at predicting how drugs will work before ...

Kos Biotechnology invests in Golden Age Health to widen rare disease access in Asia-Pacific.

EUCROF says the upcoming Ukrainian CRO Association will help show the country remains a strong location for drug trials ...

BMS halted the study earlier this year following three patient deaths in a competitor’s trial.

Anthropic, the AI lab behind Claude, has filed to go public on Nasdaq under ticker "ANT," though key offering details remain ...